A number of investment brokers have recently updated their price targets on shares of Acura Pharmaceuticals, Inc. (ACUR).

Most recent broker ratings

04/14/2016 – Acura Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Roth Capital. They now have a USD 6 price target on the stock.

06/17/2015 – Acura Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at MLV & Co. They now have a USD 2 price target on the stock.

06/03/2014 – Acura Pharmaceuticals, Inc. was downgraded to “sell” by analysts at TheStreet.

The share price of Acura Pharmaceuticals, Inc. (ACUR) was down -0.79% during the last trading session, with a day high of 2.78. 13031 shares were traded on Acura Pharmaceuticals, Inc.’s last session.

The stock’s 50 day moving average is 2.90 and its 200 day moving average is 2.40. The stock’s market capitalization is 29.62M. Acura Pharmaceuticals, Inc. has a 52-week low of 1.61 and a 52-week high of 6.75.

View other investors thoughts on Acura Pharmaceuticals, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.